Medication Safety in Intravenous Therapy: Compatibility of Etoposide With Frequently Drugs Used in Tumour Critical Care During Simulated Y-Site Administration [Corrigendum]

Ding H, Tong T, Liu S, Tang L, Chen Z. Drug Des Devel Ther. 2025;19:1147—1161.

The authors have advised there is an error in Figure 1 on page 1151. The text “Particles > 25 µm≤25 particles/mL” should read “Particles > 25 µm≤ 3 particles/mL”. The correct Figure 1 is as follows.

Figure 1 Diagram of compatibility justification.

The authors apologize for this error.

Read the original article

© 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, 3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.